Stock listing
Grace Therapeutics, Inc.
Selected listing: A40LEL · LS · EUR · DE
Grace Therapeutics, Inc. (Lang & Schwarz: A40LEL), Health Technology. Latest release Sep 3, 2026: Grace Therapeutics to Participate in the H.C. Wainright 28th…
- Ticker
- Lang & Schwarz: A40LEL
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Lang & Schwarz
- Currency
- EUR
About Grace Therapeutics, Inc.
The company focuses on developing innovative therapies in the healthcare sector. As a public entity, Grace Therapeutics is subject to regulatory oversight and provides transparency to its investors.
Latest news from Grace Therapeutics, Inc.
Grace Therapeutics to Participate in the H.C. Wainright 28th Annual Global Investment Conference
September 3, 2026
Grace Therapeutics Announces First Quarter 2027 Financial Results, Provides Business Update
August 13, 2026
Grace Therapeutics Announces $10 Million Private Placement
August 3, 2026
Grace Therapeutics Announces Receipt of Type A Meeting Minutes from U.S. Food and Drug Administration
July 28, 2026
Grace Therapeutics Announces 2026 Fiscal Year-End Financial Results, Provides Business Update
June 18, 2026
Events
Research Grace Therapeutics, Inc.
Grace Therapeutics, Inc. company profile
View the public company page for Grace Therapeutics, Inc. on 6ix.
Grace Therapeutics, Inc. news
Read company news and market updates connected to Grace Therapeutics, Inc..
Grace Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Grace Therapeutics, Inc..
Alternate listings
GRCE:NASDAQ
US · USD
Alternate listing for Grace Therapeutics, Inc.; the primary context on this page is A40LEL:LS.
GRCE:BOATS
US · USD
Alternate listing for Grace Therapeutics, Inc.; the primary context on this page is A40LEL:LS.
L8S:FWB
DE · EUR
Alternate listing for Grace Therapeutics, Inc.; the primary context on this page is A40LEL:LS.